Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Cancer Genetics buys CRO vivoPharm for $12mm in cash and stock

Executive Summary

Cancer Genetics Inc. (CGI) acquired privately held Australian CRO vivoPharm Pty. Ltd. for $12mm ($1.2mm in cash and $10.8mm in CGI shares (3mm shares)). The acquisition was partially funded with a concurrent CGI private financing agreement.
Deal Industry
  • Biotechnology
    • Drug Discovery Tools
  • Contract Research, Toxicology Testing-CRO
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Acquisition
    • Intra-Biotech Deal
    • Full Acquisition
    • Acquisition of Private Biotech
    • Payment Includes Cash
    • Payment Includes Stock

Related Companies